COVID-19 – Indonesia to produce antiviral Molnupiravir in April 2022
Jakarta (Indonesia Window) – The Indonesian Health Ministry in collaboration with PT Amarox Pharma Global will produce antiviral Molnupiravir in the country for...
Indonesia Window
15 January 2022
COVID-19 – Indonesia issues emergency use authorization for Molnupiravir antivirus
Jakarta (Indonesia Window) – Indonesia’s National Agency of Drug and Food Control (BPOM) has issued an emergency use authorization (EUA) for the COVID-19 antivi...
COVID-19 – Four antiviral drugs get emergency use in Indonesia
"The four drugs are Favipiravir, Remdesivir, Regdanvimab and Molnupiravir." Jakarta (Indonesia Window) – Currently, there are four types of drugs that have rece...
01 July 2022
COVID-19 – Indonesia issues EUA for Paxlovid as medicine
"The recommended dose is 300 mg Nirmatrelvir (two 150 mg tablets) with 100 mg Ritonavir (one 100 mg tablet) taken together twice a day for five days." Jakarta (...
18 July 2022
